title: Desmoglein 3-specific T regulatory 1 cells consist of two subpopulations with differential expression of the transcription factor Foxp3.
abstract: Pemphigus vulgaris (PV) is an autoimmune bullous skin disorder associated with autoantibodies against desmoglein (Dsg) 3. An imbalance of type 1 regulatory T (Tr1) cells and T helper type 2 (Th2) cells specific for Dsg3 may be critical for the loss of tolerance against Dsg3 in PV. Within the population of Dsg3-responsive, interleukin (IL)-10-secreting Tr1 cell clones, two major subpopulations were identified and sorted by fluorescence-activated cell sorting (FACS) based on their size and granularity. Upon in vitro culture, the larger subpopulation differentiated back into the two former subpopulations of the Tr1 cell clones, while the smaller subpopulation died within 2 weeks. The smaller subpopulation of the Tr1 cell clones was characterized by the expression of Foxp3, the secretion of IL-10, transforming growth factor (TGF)-beta and IL-5 upon stimulation with Dsg3, a proliferative response to IL-2 but not to Dsg3 or mitogenic stimuli, and an inhibitory effect on the proliferative response of Dsg3-responsive Th clones in a Dsg3-specific manner. In contrast, the larger subpopulation showed a Th-like phenotype, lacking Foxp3, cytotoxic T-lymphocyte antigen 4 (CTLA4) and glucocorticoid-induced tumour necrosis factor receptor (GITR) expression and IL-2 secretion, and did not mount a proliferative response to Dsg3 and mitogenic stimuli. The two Tr1 subpopulations showed expression of identical T-cell receptor (TCR) V beta chains which varied among the PV patients studied. Upon inhibition of Foxp3, the smaller Tr1 subpopulation developed a proliferate response to Dsg3 and mitogenic stimuli, no longer suppressed Dsg3-specific Th cells, lost expression of GITR and CTLA4 and secreted IL-2. Thus, our observations suggest a distinct relationship between Dsg3-specific Tr1 and Th-like cells which may be critical for the continuous generation and survival of Dsg3-specific Tr1 cells.
authors.affiliation: Department of Dermatology, University of Marburg, Marburg, Germany. hertl@med.uni-marburg.de
authors.forename: Christian
authors.initials: C
authors.lastname: Veldman
authors.forename: Andreas
authors.initials: A
authors.lastname: Pahl
authors.forename: Michael
authors.initials: M
authors.lastname: Hertl
mesh_terms: D015551:Autoimmunity / Q000276:immunology; D049109:Cell Proliferation; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis; D051184:Desmoglein 3 / Q000276:immunology*; D051858:Forkhead Transcription Factors / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology; D016130:Immunophenotyping; D008213:Lymphocyte Activation / Q000276:immunology; D016376:Oligonucleotides, Antisense / Q000276:immunology; D010392:Pemphigus / Q000276:immunology*; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D016176:T-Lymphocyte Subsets / Q000276:immunology*; D050378:T-Lymphocytes, Regulatory / Q000276:immunology*
chemical_list: D016207:Cytokines; C071894:DSG3 protein, human; D051184:Desmoglein 3; C418974:FOXP3 protein, human; D051858:Forkhead Transcription Factors; D016376:Oligonucleotides, Antisense
references.citation: Nature. 2003 Jan 23;421(6921):388-92
references.pmid: 12540904
references.citation: Science. 2003 Feb 14;299(5609):1057-61
references.pmid: 12522256
references.citation: Nat Immunol. 2003 Apr;4(4):330-6
references.pmid: 12612578
references.citation: Nat Immunol. 2003 Apr;4(4):337-42
references.pmid: 12612581
references.citation: Transplantation. 2003 May 15;75(9 Suppl):8S-12S
references.pmid: 12819483
references.citation: N Engl J Med. 2003 Nov 13;349(20):1907-15
references.pmid: 14614165
references.citation: J Exp Med. 2003 Dec 15;198(12):1807-15
references.pmid: 14676295
references.citation: J Exp Med. 2003 Dec 15;198(12):1875-86
references.pmid: 14676299
references.citation: J Clin Invest. 2004 Feb;113(3):451-63
references.pmid: 14755342
references.citation: J Immunol. 2004 Mar 15;172(6):3883-92
references.pmid: 15004196
references.citation: J Immunol. 2004 May 1;172(9):5149-53
references.pmid: 15100250
references.citation: J Immunol. 2004 May 15;172(10):6468-75
references.pmid: 15128839
references.citation: Cell. 1991 Nov 29;67(5):869-77
references.pmid: 1720352
references.citation: J Clin Invest. 1992 Sep;90(3):919-26
references.pmid: 1522242
references.citation: Nature. 1992 Oct 22;359(6397):693-9
references.pmid: 1436033
references.citation: J Clin Invest. 1997 Jan 1;99(1):31-40
references.pmid: 9011573
references.citation: J Cell Biol. 1997 Jun 2;137(5):1091-102
references.pmid: 9166409
references.citation: Nature. 1997 Oct 16;389(6652):737-42
references.pmid: 9338786
references.citation: J Clin Invest. 1999 Feb;103(4):461-8
references.pmid: 10021453
references.citation: Blood. 2005 Feb 1;105(3):1162-9
references.pmid: 15479730
references.citation: J Exp Med. 2005 Apr 4;201(7):1061-7
references.pmid: 15809351
references.citation: Lancet. 2005 Jul 2-8;366(9479):61-73
references.pmid: 15993235
references.citation: Gene Ther. 2005 Sep;12(17):1294-304
references.pmid: 15973443
references.citation: J Clin Invest. 2005 Nov;115(11):3276-84
references.pmid: 16211090
references.citation: J Immunol. 2006 Mar 1;176(5):3215-22
references.pmid: 16493082
references.citation: Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6659-64
references.pmid: 16617117
references.citation: J Immunol. 2006 Sep 15;177(6):3806-13
references.pmid: 16951342
references.citation: Immunology. 2007 Mar;120(3):392-403
references.pmid: 17239200
references.citation: Science. 2007 Jul 13;317(5835):256-60
references.pmid: 17569825
references.citation: J Exp Med. 2007 Aug 6;204(8):1757-64
references.pmid: 17620361
references.citation: J Exp Med. 2007 Aug 6;204(8):1775-85
references.pmid: 17620362
references.citation: J Exp Med. 2007 Aug 6;204(8):1737-9
references.pmid: 17620364
references.citation: Nat Immunol. 2007 Sep;8(9):931-41
references.pmid: 17694059
references.citation: J Immunol. 2003 Jan 1;170(1):635-42
references.pmid: 12496453
references.citation: J Invest Dermatol. 2000 Jan;114(1):88-94
references.pmid: 10620121
references.citation: J Clin Invest. 2000 Mar;105(5):625-31
references.pmid: 10712434
references.citation: Nat Genet. 2001 Jan;27(1):68-73
references.pmid: 11138001
references.citation: Nat Med. 2001 Jan;7(1):114-8
references.pmid: 11135625
references.citation: J Immunol. 2001 May 1;166(9):5530-9
references.pmid: 11313392
references.citation: Skin Pharmacol Appl Skin Physiol. 2001 Nov-Dec;14(6):408-18
references.pmid: 11598441
references.citation: J Immunol. 2001 Dec 1;167(11):6312-20
references.pmid: 11714795
references.citation: J Exp Med. 2001 Dec 17;194(12):1711-9
references.pmid: 11748273
references.citation: J Exp Med. 2002 Mar 4;195(5):603-16
references.pmid: 11877483
references.citation: Br J Pharmacol. 2002 Apr;135(8):1915-26
references.pmid: 11959794
references.citation: Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6192-7
references.pmid: 11972069
references.citation: Eur J Immunol. 2002 Aug;32(8):2237-45
references.pmid: 12209636